Key Issue for industrial biotech companies is gene containment which requires a gene firewall which Syngulon developed based on bacteriocins. Syngulon owns a fully patented technology enabling gene containment and genetic shielding for industrial biotech. Syngulon are looking for industrial partners to join the PARAGEN project financed by the Belgium Wallonie Region.
RELATED ARTICLES
- What are Bioplastics and Biopolymers?
- Bioplastics Brands
- Bioplastics Awards
- What is the Difference Between Biodegradable, Compostable and OXO Degradable?
- The History and Most Important Innovations of Bioplastics
- What are Drop-In Bioplastics?
- History of Cellophane
- The History of Elephant Grass Bioplastics
- Bioplastics Companies
- Top Bioplastics Producers
- Polylactic acid or polylactide (PLA)
- What is Bio-BDO?
- McDonalds and the Polystyrene Connections
- The Future of Polystyrene
- Bioplastic Feedstock 1st, 2nd and 3rd Generations
- Palm Oil and The Bioplastics Industry
